Laboratory Corporation of... (LH)
undefined
undefined%
At close: undefined
232.01
-0.19%
After-hours Dec 13, 2024, 04:10 PM EST

Company Description

Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.

It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD).

It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests.

The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests.

It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations and accountable care organizations.

It offers end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access.

It serves managed care organizations, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories.

Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color.

The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

Laboratory Corporation of America
Laboratory Corporation of America logo
Country United States
IPO Date Mar 29, 1990
Industry Medical - Diagnostics & Research
Sector Healthcare
Employees 67,000
CEO Adam H. Schechter

Contact Details

Address:
358 South Main Street
Burlington, North Carolina
United States
Website https://www.labcorp.com

Stock Details

Ticker Symbol LH
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000920148
CUSIP Number 50540R409
ISIN Number US50540R4092
Employer ID 13-3757370
SIC Code 8071

Key Executives

Name Position
Adam H. Schechter President, Chief Executive Officer & Chairman
Glenn A. Eisenberg Special Advisor to the Chief Executive Officer
Julia Wang Chief Financial Officer & Executive Vice President
Mark S. Schroeder Executive Vice President, President of Diagnostics Laboratories & Chief Operating Officer
Sandra D. van der Vaart J.D. Executive Vice President, Chief Legal Officer & Corporate Secretary
Anita Z. Graham Executive Vice President & Chief Human Resources Officer
Christin O'Donnell Vice President of Investor Relations
Dr. Brian J. Caveney J.D., M.D., M.P.H. EVice President, President of Early Development Research Laboratories and Chief Medical & Scientific Officer
Dr. Marcia T. Eisenberg Ph.D. Enterprise Chief Scientific Officer & Senior Vice President
Peter J. Wilkinson Senior Vice President & Chief Accounting Officer

Latest SEC Filings

Date Type Title
Dec 04, 2024 4 Filing
Dec 04, 2024 4 Filing
Dec 04, 2024 4 Filing
Dec 03, 2024 3 Filing
Nov 26, 2024 4 Filing
Nov 25, 2024 4 Filing
Nov 19, 2024 8-K Current Report
Nov 13, 2024 4 Filing
Nov 05, 2024 4 Filing
Nov 05, 2024 4 Filing